Tell your healthcare provider if you are taking medicines to treat diabetes including an insulin or sulfonylurea
Key Takeaways Switching from Mounjaro to Wegovy is possible and safe when done under clinical guidance A one-week gap between your last Mounjaro dose and first Wegovy dose is usually enough Your prescriber may start your Wegovy dose at a lower level as compared to your latest Mounjaro dose There may be a short adjustment period, but your weight loss journey should typically resume after that Wegovy 7.2mg, the highest semaglutide dose now available, has now been approved in the UK since January 2026 Wegovy is now also licensed to reduce the risk of heart attacks and strokes in eligible patients At SheMed, we manage every switch with a full blood test and clinician-led dose review from day one Why Patients Switch from Mounjaro to Wegovy Weve already mentioned some of the reasons in the intro paragraph
GLP-1 prescriptions, outpacing the combined 46% share of Novo Nordisk's Wegovy and its diabetes treatment Ozempic, according to Seigerman
This case will also influence future regulatory thinking on how to manage high-cost therapies and ensure equitable access to life-changing medications.
GLP-1 is a hormone naturally produced in the gut that functions in regulating blood sugar levels, insulin secretion, and appetite
Scroll to Indication Important Safety Information Do not share your Ozempic pen with other people, even if the needle has been changed
